黑料网

ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 4334

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Recuperation of chronic cerebral hypoperfusion induced behavioral, biochemical and structural impairments by cysteinyl leukotriene-1 receptors modulator, originally approved as an anti-asthmatic

4th International Conference on Vascular Dementia

Bhupesh Sharma and Prabhat Singh

Amity University, India

Posters & Accepted Abstracts: J Alzheimers Dis Parkinsonism

DOI:

Abstract
Objectives: Chronic cerebral hypoperfusion (CCH) is a general pathophysiological condition occurring in vascular dementia (VaD) associated with negative impact on cognitive functions. Cysteinyl leukotriene-1 receptors (CysLT1R) are extensively present in the central nervous system, where they participate in regulation of cognition, motivation, inflammation and neurodegeneration. The purpose of this study is to examine the role of montelukast; a specific CysLT1 antagonist in CCH induced VaD in mice. Methods: Two vessel occlusion (2VO) or permanent ligation of bilateral common carotid arteries technique was used to induce CCH in mice. Animals were assessed for learning and memory (Morris water maze), cholinergic function (increased acetylcholinesterase activity), brain inflammation, brain oxidative stress (brain superoxide dismutase, glutathione, catalase and thiobarbituric acid reactive substance level) and brain damage (brain infarct size using 2, 3, 5-triphenylterazolium chloride staining). Results: Animals with bilateral carotid arteries occlusion have revealed impaired learning and memory, cholinergic dysfunction (increased acetylcholinesterase activity), brain inflammation, brain oxidative stress (reduction in brain superoxide dismutase, glutathione and catalase with an increase in thiobarbituric acid reactive substance level), with increased brain infarct size (2,3,5-triphenylterazolium chloride staining). The administration of montelukast considerably attenuated CCH induced cognitive impairments, cholinergic dysfunction, brain inflammation, brain oxidative stress as well as brain damage. Conclusions: The results of this study suggest that CCH has induced VaD in animals, which was attenuated by the treatment with montelukast, a specific modulator of CysLT1receptors. This is the first study which reports the utility of montelukast in experimental VaD. Future research should be targeted towards identification of various possible mechanisms of CysLT1receptor modulators in VaD and associated conditions.
Biography

Email: drbhupeshresearch@gmail.com bsharma5@amity.edu

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top